Thursday, 2 February 2012

Oxbridge-London Biotech Roundtable Presents:

How IP turns scientific breakthroughs into profitable ventures

WHAT: Two professionals with extensive experience in advising their clients on how to protect their ideas and create value from them are joined in a panel discussion by the recent founder of a medical imaging company. Focusing on the biotech sector, they will be discussing the critical importance of IP, potential pitfalls, how to know how much one’s ideas are worth and much more. WHEN: 6pm, 9 Feb 2012WHERE: Imperial College London, Electrical and Electronic Engineering Building LT408, SW7 2AZ

Quinton Fivelman is the Business Development Manager of IP Pragmatics, who help their clients identify, manage and create value from a broad range of intellectual property assets through a combination of value creation and cost management services. He is a Visiting Research Fellow at the London School of Hygiene and Tropical Medicine as well as the Director and co-founder of the education provider Enter-rise Ltd as well as a member of the non-profit research group DevelopMed.
Janita Good is a partner at the Reading office of the law firm Osborne Clarke and head of the Life Science Sector (Thames Valley). Her work focuses on corporate and intellectual property transactions, especially in the biotechnology sector, underpinned by her D.Phil. in biochemistry. She is a member of a range of professional bodies and sits on the IP advisory board for the Bio Industry Association.

Signup HERE

If you are interested in joining the OBR-team at QMUL email:
Other OBR-London events:
Risky Business: The Pharma Game (Feb 21, 22, 24)The Biotech Debate: “This house believes UK biotech is dead” (Mar 16)